Ibrutinib for the treatment of chronic graft‐vs‐host disease in pediatric hematopoietic stem cell transplant patients: A single‐center experience
2021 ◽
Vol 27
(3)
◽
pp. S289-S290
2020 ◽
Vol 28
(1)
◽
pp. 10-15
2016 ◽
Vol 22
(3)
◽
pp. S161
◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. e18003-e18003
2017 ◽
Vol 23
(3)
◽
pp. S484-S485
2019 ◽
Vol 25
(3)
◽
pp. S250-S251
2019 ◽
Vol 25
(3)
◽
pp. S286-S287